These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6152988)
21. Cefoxitin: its role in treatment and prophylaxis of obstetric and gynecologic infections. Counts GW Rev Infect Dis; 1988; 10(1):76-91. PubMed ID: 3281224 [TBL] [Abstract][Full Text] [Related]
23. Comparative clinical evaluation of a new cephyamycin antibiotic, cefoxitin, in acute bacterial infections. Del Negro G; Francisco W; Godoy CV Rev Inst Med Trop Sao Paulo; 1980; 22(1):30-6. PubMed ID: 7001604 [No Abstract] [Full Text] [Related]
24. [The clinical diagnosis and treatment of ascending infections of the genitalia by using the combined preparation ampicillin/sulbactam (Unasyn)]. Eibach HW Antibiot Khimioter; 1991 Jun; 36(6):13-5. PubMed ID: 1832852 [No Abstract] [Full Text] [Related]
25. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections. Weigelt JA Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262 [TBL] [Abstract][Full Text] [Related]
26. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis]. Vasiljević M; Marković A; Ganović R; Jovanović R Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846 [TBL] [Abstract][Full Text] [Related]
27. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology. Chan JC Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324 [TBL] [Abstract][Full Text] [Related]
28. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections. LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621 [TBL] [Abstract][Full Text] [Related]
29. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of cefoperazone in obstetric and gynecologic infections. Ling FW; McNeeley SG; Anderson GD; Buxton BH; Hester MG Clin Ther; 1984; 6(5):669-76. PubMed ID: 6383613 [TBL] [Abstract][Full Text] [Related]
31. Clinical and bacteriological evaluation of cefoxitin therapy in children. Jacobson JA; Santos JI; Palmer WM Antimicrob Agents Chemother; 1979 Aug; 16(2):183-5. PubMed ID: 485129 [TBL] [Abstract][Full Text] [Related]
32. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients]. Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361 [TBL] [Abstract][Full Text] [Related]
33. Infections in the female genital tract. Gall SA Compr Ther; 1983 Aug; 9(8):34-47. PubMed ID: 6413123 [TBL] [Abstract][Full Text] [Related]
34. Treatment of acute pelvic infections with alphacillin (pivampicillin Hcl). Grech ES; Mutale EM; Bathirunatham N Med J Zambia; 1977; 11(4):99-103. PubMed ID: 919787 [TBL] [Abstract][Full Text] [Related]
35. Clinical trial of cefoxitin (mefoxin) in parenteral therapy of septicemia (postabortal and postpartum) in Ibadan. Adelusi B; Osoba AO; Adetoro OA; Ojengbede AO; Adeyemi-Doro FA; Rotowa NA Afr J Med Med Sci; 1985; 14(1-2):31-5. PubMed ID: 2994436 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. A comparative study. de Beer JA; van den Ende J; Odendaal HJ S Afr Med J; 1983 Oct; 64(19):733-6. PubMed ID: 6353623 [TBL] [Abstract][Full Text] [Related]